FDA seeks Comments on Ways to Avoid Gluten in Drug Products
The Food and Drug Administration is seeking comments and information that will assist it in its deliberations about ways to help individuals with celiac disease avoid the presence of gluten in drug products. In particular, FDA is interested in information…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
on ingredients present in human drug products marketed in the U.S. that are currently derived from wheat, barley, or rye. Comments are due by February 21, 2012.